Key Deals: Gildan Activewear Acquires HanesBrands, Teladoc Health, and More
ByAinvest
Monday, Aug 18, 2025 5:29 am ET1min read
GIL--
The transaction, expected to close in late 2025 or early 2026, will see Gildan shareholders own approximately 19.9% of Gildan shares on a non-diluted basis upon closing. HanesBrands shareholders will receive 0.102 common shares of Gildan and $0.80 in cash for each share of HanesBrands common stock, representing a premium of approximately 24% to HanesBrands' closing price on August 11, 2025 [1].
The combined entity is expected to achieve significant cost synergies, with at least $200 million in annual run-rate cost synergies within three years of closing. This includes $50 million in 2026, $100 million in 2027, and $50 million in 2028 [1]. The deal is expected to be immediately accretive to Gildan's adjusted diluted EPS and 20%+ accretive to adjusted diluted EPS pro forma for expected run-rate cost synergies of $200 million.
Gildan's headquarters will remain in Montréal, Québec, while the combined company will maintain a strong presence in Winston-Salem, North Carolina. Gildan also plans to review strategic alternatives for HanesBrands Australia, which could include a sale or other transaction [1].
Other notable deals reported this week include Sapiens acquisition of Perplexity and Teladoc Health's acquisition of Advance Medical [1].
References:
[1] https://ir.hanesbrands.com/news-releases/news-release-details/gildan-and-hanesbrands-agree-combine-create-global-basic-apparel
HBI--
Gildan Activewear has agreed to acquire HanesBrands in a deal with an implied equity value of ~$2.2 billion and an enterprise value of ~$4.4 billion. Other key deals reported this week include Sapiens acquisition of Perplexity, and Teladoc Health's acquisition of Advance Medical.
Gildan Activewear Inc. (GIL: TSX, GIL: NYSE) has announced a definitive merger agreement to acquire HanesBrands Inc. (HBI: NYSE) in a deal valued at approximately $2.2 billion in equity and $4.4 billion in enterprise value [1]. The acquisition will create a global leader in basic apparel, combining Gildan's strengths in activewear with HanesBrands' leading innerwear brands and retail presence.The transaction, expected to close in late 2025 or early 2026, will see Gildan shareholders own approximately 19.9% of Gildan shares on a non-diluted basis upon closing. HanesBrands shareholders will receive 0.102 common shares of Gildan and $0.80 in cash for each share of HanesBrands common stock, representing a premium of approximately 24% to HanesBrands' closing price on August 11, 2025 [1].
The combined entity is expected to achieve significant cost synergies, with at least $200 million in annual run-rate cost synergies within three years of closing. This includes $50 million in 2026, $100 million in 2027, and $50 million in 2028 [1]. The deal is expected to be immediately accretive to Gildan's adjusted diluted EPS and 20%+ accretive to adjusted diluted EPS pro forma for expected run-rate cost synergies of $200 million.
Gildan's headquarters will remain in Montréal, Québec, while the combined company will maintain a strong presence in Winston-Salem, North Carolina. Gildan also plans to review strategic alternatives for HanesBrands Australia, which could include a sale or other transaction [1].
Other notable deals reported this week include Sapiens acquisition of Perplexity and Teladoc Health's acquisition of Advance Medical [1].
References:
[1] https://ir.hanesbrands.com/news-releases/news-release-details/gildan-and-hanesbrands-agree-combine-create-global-basic-apparel

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet